Danaher | DHR - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 364M 78M 2025-12
Align Technology USD 148.89M 27.71M 2026-03
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Boston Scientific USD 700M 238M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Edwards Lifesciences USD 348.4M 51.8M 2025-09
ESCO Technologies USD 35.48M 24.09M 2025-12
Fortive USD 193.9M 58.9M 2025-12
Henry Schein USD 150M 17M 2026-03
Illumina USD 157M 220M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 6.22B 5.68B 2026-03
Keysight Technologies USD 198M 187M 2025-12
Laboratory Of America USD 8.73B 8.54B 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Roper Industries USD 534.6M 36.4M 2025-12
Stryker USD 1.7B 676M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 264.18M 94.06M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12